We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$164B
AUM Growth
+$34B
Cap. Flow
+$21.1B
Cap. Flow %
12.82%
Top 10 Hldgs %
19.02%
Holding
8,908
New
1,440
Increased
3,569
Reduced
2,696
Closed
989

Sector Composition

Rank Sector Weight
1 Technology 6.08%
2 Financials 6.03%
3 Industrials 5.01%
4 Consumer Discretionary 4.73%
5 Healthcare 4.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTHR
8376
DELISTED
Charles & Colvard Ltd
CTHR
-1,663
Closed -$14K
CMLS
8377
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
-75,092
Closed -$24K
ICD
8378
DELISTED
Independence Contract Drilling, Inc.
ICD
-532
Closed -$40K
CEM
8379
DELISTED
ClearBridge MLP and Midstream Fund Inc.
CEM
-5,744
Closed -$426K
NBSE
8380
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
-64
Closed -$18K
FPL
8381
DELISTED
FIRST TRUST NEW OPPORTUNITIES MLP & ENERGY FUND
FPL
-11,789
Closed -$149K
AYX
8382
DELISTED
Alteryx Inc
AYX
-354,954
Closed -$7.23M
ESHY
8383
DELISTED
Xtrackers J.P. Morgan ESG USD High Yield Corporate Bond ETF
ESHY
-13,159
Closed -$306K
BFX
8384
CALL
DELISTED
BowFlex Inc.
BFX
-10,700
Closed -$181K
NSTG
8385
DELISTED
NanoString Technologies, Inc.
NSTG
-78,038
Closed -$1.26M
DMK
8386
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
-210
Closed -$77K
SRC
8387
PUT
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-5,486
Closed -$211K
NETI
8388
PUT
DELISTED
Eneti Inc.
NETI
-1,517
Closed -$99K
BSJN
8389
DELISTED
Invesco BulletShares 2023 High Yield Corporate Bond ETF
BSJN
-21,484
Closed -$578K
PCTI
8390
DELISTED
PCTEL, Inc. Common Stock
PCTI
-16,101
Closed -$101K
HEP
8391
DELISTED
Holly Energy Partners, L.P.
HEP
-25,762
Closed -$857K
PACW
8392
PUT
DELISTED
PacWest Bancorp
PACW
-6,100
Closed -$308K
AVTA
8393
CALL
DELISTED
Avantax, Inc. Common Stock
AVTA
-16,400
Closed -$415K
SCU
8394
CALL
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-1,710
Closed -$55K
SCU
8395
PUT
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-1,090
Closed -$35K
AEY
8396
DELISTED
ADDvantage Technologies Group
AEY
-1,046
Closed -$14K
NXGN
8397
CALL
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
-16,600
Closed -$261K
NEWR
8398
DELISTED
New Relic, Inc.
NEWR
-173,162
Closed -$9.42M
NEWR
8399
PUT
DELISTED
New Relic, Inc.
NEWR
-4,700
Closed -$234K
ICPT
8400
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-28,205
Closed -$1.78M

Similar funds

Citadel Advisors's Q4 2017 Portfolio in Review

As of Q4 2017, Citadel Advisors held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Citadel Advisors deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.

By sector, the portfolio is most concentrated in Technology at 6.1% of assets, down from 7% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.

  • Citadel Advisors's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
  • Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
  • Citadel Advisors's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
  • Citadel Advisors fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
  • Citadel Advisors's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
  • Citadel Advisors opened 1,440 new positions and closed 989 in Q4 2017.
  • Citadel Advisors's portfolio value rose 26% quarter-over-quarter to $164B.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.